Rhythm Pharmaceuticals, Inc. (RYTM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1240145,
    "name": "Rhythm Pharmaceuticals, Inc.",
    "stock_name": "Rhythm Pharmaceuticals, Inc.",
    "full_name": "Rhythm Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/rhythm-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "105.70",
    "chg": 4.31,
    "chgp": "4.25%",
    "dir": 1,
    "prev_price": "101.39",
    "mcapval": "6,626.73",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US76243J1051",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.15 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rhythm-pharmaceuticals-inc-1240145-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Rhythm Pharmaceuticals Hits New 52-Week High of $116.00",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rhythm-pharmaceuticals-hits-new-52-week-high-of-11600-3661955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RhythmPharmaceu_priceRelatedfactors_3661955.png",
        "date": "2025-10-31 16:15:55",
        "description": "Rhythm Pharmaceuticals, Inc. achieved a new 52-week high of USD 116.00 on October 30, 2025, reflecting significant growth in the pharmaceuticals and biotechnology sector. The company has seen a remarkable performance increase of 172.64% over the past year, with an impressive return on equity of 1,528.51%."
      },
      {
        "title": "Rhythm Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rhythm-pharmaceuticals-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-stock-price-increase-3652102",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RhythmPharmaceu_technicaldot_3652102.png",
        "date": "2025-10-28 15:49:03",
        "description": "Rhythm Pharmaceuticals, Inc. has recently revised its evaluation amid changing market dynamics. The stock is currently priced at $111.55, reflecting a strong annual return of 124.40%. Technical indicators present a mixed outlook, with bullish signals in some areas and bearish tendencies in others, highlighting ongoing volatility."
      },
      {
        "title": "Is Rhythm Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rhythm-pharmaceuticals-inc-technically-bullish-or-bearish-3651330",
        "imagepath": "",
        "date": "2025-10-28 11:40:42",
        "description": "As of 24 October 2025, the technical trend for Rhythm Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, while the Bollinger Bands also indicate bullishness across both time frames. The daily moving averages confirm a bullish stance. However, the weekly and monthly RSI readings are bearish, suggesting some weakness in momentum. The KST is mildly bearish on both weekly and monthly charts, and Dow Theory shows no trend weekly but is bullish monthly. Overall, the stock is currently bullish, driven by strong momentum indicators despite some bearish signals in RSI and KST.\n\nIn terms of performance, the stock has significantly outperformed the S&P 500 across all periods, with a year-to-date return of 97.34% compared to the S&P 500's 15.47%, and a one-year return of 122.23% versus 16.90%...."
      },
      {
        "title": "Is Rhythm Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rhythm-pharmaceuticals-inc-technically-bullish-or-bearish-3647783",
        "imagepath": "",
        "date": "2025-10-27 11:51:48",
        "description": "As of 24 October 2025, the technical trend for Rhythm Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators from the moving averages and Bollinger Bands on both weekly and monthly timeframes. The MACD is also bullish on both timeframes, while the Dow Theory shows a bullish monthly trend. However, the RSI and KST are bearish on the weekly and monthly, indicating some weakness. \n\nIn terms of performance, the stock has significantly outperformed the S&P 500, with a year-to-date return of 97.34% compared to the S&P 500's 15.47%, and a one-year return of 122.23% versus 16.90%...."
      },
      {
        "title": "Is Rhythm Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rhythm-pharmaceuticals-inc-technically-bullish-or-bearish-3646312",
        "imagepath": "",
        "date": "2025-10-26 11:26:23",
        "description": "As of 24 October 2025, the technical trend for Rhythm Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals from the MACD on both weekly and monthly time frames, as well as bullish readings from the Bollinger Bands and daily moving averages. However, the RSI is bearish on both weekly and monthly time frames, indicating some weakness. The Dow Theory shows a bullish monthly trend but no trend on the weekly. Despite some mixed signals, the overall strength leans towards bullish.\n\nIn terms of performance, the company has significantly outperformed the S&P 500, with a year-to-date return of 97.34% compared to the S&P 500's 15.47%, and a one-year return of 122.23% versus 16.90%...."
      },
      {
        "title": "Rhythm Pharmaceuticals Hits New 52-Week High of $109.68",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rhythm-pharmaceuticals-hits-new-52-week-high-of-10968-3626628",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RhythmPharmaceu_priceRelatedfactors_3626628.png",
        "date": "2025-10-16 18:19:39",
        "description": "Rhythm Pharmaceuticals, Inc. achieved a new 52-week high of USD 109.68 on October 15, 2025, reflecting a significant one-year performance increase. The company, with a market capitalization of USD 6,627 million, has notable financial metrics but remains loss-making, navigating challenges in the biotechnology sector."
      },
      {
        "title": "Rhythm Pharmaceuticals Hits New 52-Week High of $106.84",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rhythm-pharmaceuticals-hits-new-52-week-high-of-10684-3622789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RhythmPharmaceu_priceRelatedfactors_3622789.png",
        "date": "2025-10-15 16:58:42",
        "description": "Rhythm Pharmaceuticals, Inc. achieved a new 52-week high of USD 106.84 on October 14, 2025, reflecting strong performance in the pharmaceuticals sector. The company has seen a 156.52% increase in stock price over the past year, significantly outperforming the S&P 500, with an impressive return on equity of 1,528.51%."
      },
      {
        "title": "Is Rhythm Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rhythm-pharmaceuticals-inc-technically-bullish-or-bearish-3546741",
        "imagepath": "",
        "date": "2025-09-20 19:39:37",
        "description": "As of 27 August 2025, the technical trend for Rhythm Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, while the daily moving averages also indicate a bullish stance. However, the weekly and monthly RSI readings are bearish, suggesting some weakness. The Bollinger Bands show a bullish trend on the weekly and mildly bullish on the monthly. The KST is bullish weekly but mildly bearish monthly, and the Dow Theory indicates a mildly bearish weekly trend but bullish monthly. Overall, the mixed signals suggest a bullish stance, albeit with some caution due to bearish RSI and KST readings.\n\nIn terms of performance, Rhythm Pharmaceuticals has significantly outperformed the S&P 500, with a year-to-date return of 76.03% compared to the S&P 500's 12.22%, and a one-year return of 83.71% versus 17.14%...."
      },
      {
        "title": "Is Rhythm Pharmaceuticals, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rhythm-pharmaceuticals-inc-overvalued-or-undervalued-3543250",
        "imagepath": "",
        "date": "2025-09-20 18:14:34",
        "description": "As of 2 November 2021, the valuation grade for Rhythm Pharmaceuticals, Inc. moved from does not qualify to risky, indicating a heightened level of uncertainty regarding its financial stability. The company appears to be overvalued given its significant negative financial metrics, including a Price to Book Value of 228.70, an EV to EBIT of -24.75, and an EV to EBITDA of -24.97. These ratios suggest that the company is struggling to generate positive earnings relative to its valuation.\n\nIn comparison to its peers, Rhythm Pharmaceuticals, Inc. has a P/E ratio of -36.41, which is significantly worse than Merus NV at -13.18 and CymaBay Therapeutics, Inc. at -35.38, highlighting its relative overvaluation in the market. Despite its strong year-to-date return of 76.03% compared to the S&P 500's 12.22%, this performance does not mitigate the concerns raised by its negative financial ratios, reinforcing the conclusi..."
      }
    ],
    "total": 15,
    "sid": "1240145",
    "stock_news_url": "https://www.marketsmojo.com/news/rhythm-pharmaceuticals-inc-1240145"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Rhythm Pharmaceuticals Hits New 52-Week High of $116.00

2025-10-31 16:15:55

Rhythm Pharmaceuticals, Inc. achieved a new 52-week high of USD 116.00 on October 30, 2025, reflecting significant growth in the pharmaceuticals and biotechnology sector. The company has seen a remarkable performance increase of 172.64% over the past year, with an impressive return on equity of 1,528.51%.

Rhythm Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-10-28 15:49:03

Rhythm Pharmaceuticals, Inc. has recently revised its evaluation amid changing market dynamics. The stock is currently priced at $111.55, reflecting a strong annual return of 124.40%. Technical indicators present a mixed outlook, with bullish signals in some areas and bearish tendencies in others, highlighting ongoing volatility.

Is Rhythm Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-28 11:40:42

As of 24 October 2025, the technical trend for Rhythm Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, while the Bollinger Bands also indicate bullishness across both time frames. The daily moving averages confirm a bullish stance. However, the weekly and monthly RSI readings are bearish, suggesting some weakness in momentum. The KST is mildly bearish on both weekly and monthly charts, and Dow Theory shows no trend weekly but is bullish monthly. Overall, the stock is currently bullish, driven by strong momentum indicators despite some bearish signals in RSI and KST. In terms of performance, the stock has significantly outperformed the S&P 500 across all periods, with a year-to-date return of 97.34% compared to the S&P 500's 15.47%, and a one-year return of 122.23% versus 16.90%....

Is Rhythm Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-27 11:51:48

As of 24 October 2025, the technical trend for Rhythm Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators from the moving averages and Bollinger Bands on both weekly and monthly timeframes. The MACD is also bullish on both timeframes, while the Dow Theory shows a bullish monthly trend. However, the RSI and KST are bearish on the weekly and monthly, indicating some weakness. In terms of performance, the stock has significantly outperformed the S&P 500, with a year-to-date return of 97.34% compared to the S&P 500's 15.47%, and a one-year return of 122.23% versus 16.90%....

Is Rhythm Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-26 11:26:23

As of 24 October 2025, the technical trend for Rhythm Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals from the MACD on both weekly and monthly time frames, as well as bullish readings from the Bollinger Bands and daily moving averages. However, the RSI is bearish on both weekly and monthly time frames, indicating some weakness. The Dow Theory shows a bullish monthly trend but no trend on the weekly. Despite some mixed signals, the overall strength leans towards bullish. In terms of performance, the company has significantly outperformed the S&P 500, with a year-to-date return of 97.34% compared to the S&P 500's 15.47%, and a one-year return of 122.23% versus 16.90%....

Rhythm Pharmaceuticals Hits New 52-Week High of $109.68

2025-10-16 18:19:39

Rhythm Pharmaceuticals, Inc. achieved a new 52-week high of USD 109.68 on October 15, 2025, reflecting a significant one-year performance increase. The company, with a market capitalization of USD 6,627 million, has notable financial metrics but remains loss-making, navigating challenges in the biotechnology sector.

Rhythm Pharmaceuticals Hits New 52-Week High of $106.84

2025-10-15 16:58:42

Rhythm Pharmaceuticals, Inc. achieved a new 52-week high of USD 106.84 on October 14, 2025, reflecting strong performance in the pharmaceuticals sector. The company has seen a 156.52% increase in stock price over the past year, significantly outperforming the S&P 500, with an impressive return on equity of 1,528.51%.

Is Rhythm Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:39:37

As of 27 August 2025, the technical trend for Rhythm Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, while the daily moving averages also indicate a bullish stance. However, the weekly and monthly RSI readings are bearish, suggesting some weakness. The Bollinger Bands show a bullish trend on the weekly and mildly bullish on the monthly. The KST is bullish weekly but mildly bearish monthly, and the Dow Theory indicates a mildly bearish weekly trend but bullish monthly. Overall, the mixed signals suggest a bullish stance, albeit with some caution due to bearish RSI and KST readings. In terms of performance, Rhythm Pharmaceuticals has significantly outperformed the S&P 500, with a year-to-date return of 76.03% compared to the S&P 500's 12.22%, and a one-year return of 83.71% versus 17.14%....

Is Rhythm Pharmaceuticals, Inc. overvalued or undervalued?

2025-09-20 18:14:34

As of 2 November 2021, the valuation grade for Rhythm Pharmaceuticals, Inc. moved from does not qualify to risky, indicating a heightened level of uncertainty regarding its financial stability. The company appears to be overvalued given its significant negative financial metrics, including a Price to Book Value of 228.70, an EV to EBIT of -24.75, and an EV to EBITDA of -24.97. These ratios suggest that the company is struggling to generate positive earnings relative to its valuation. In comparison to its peers, Rhythm Pharmaceuticals, Inc. has a P/E ratio of -36.41, which is significantly worse than Merus NV at -13.18 and CymaBay Therapeutics, Inc. at -35.38, highlighting its relative overvaluation in the market. Despite its strong year-to-date return of 76.03% compared to the S&P 500's 12.22%, this performance does not mitigate the concerns raised by its negative financial ratios, reinforcing the conclusi...

View All News